(Q43405916)

23 November 2017

title

Clinical significance of genetic aberrations in secondary acute myeloid leukemia (English)

1 reference

23 November 2017

1 reference

8

1 reference

23 November 2017

13

1 reference

23 November 2017

29

1 reference

23 November 2017

24

Jacques Colinge

1 reference

23 November 2017

Jelena D Milosevic

1

1 reference

23 November 2017

Ana Puda

2

1 reference

23 November 2017

Luca Malcovati

3

1 reference

23 November 2017

Tiina Berg

4

1 reference

23 November 2017

Michael Hofbauer

5

1 reference

23 November 2017

Alexey Stukalov

6

1 reference

23 November 2017

Thorsten Klampfl

7

1 reference

23 November 2017

Heinz Gisslinger

9

1 reference

23 November 2017

Bettina Gisslinger

10

1 reference

23 November 2017

Tatiana Burjanivova

11

1 reference

23 November 2017

Elisa Rumi

12

1 reference

23 November 2017

Chiara Elena

14

1 reference

23 November 2017

Alessandro M Vannucchi

15

1 reference

23 November 2017

Michael Doubek

16

1 reference

23 November 2017

Dana Dvorakova

17

1 reference

23 November 2017

Blanka Robesova

18

1 reference

23 November 2017

Rotraud Wieser

19

1 reference

23 November 2017

Elisabeth Koller

20

1 reference

23 November 2017

Nada Suvajdzic

21

1 reference

23 November 2017

Dragica Tomin

22

1 reference

23 November 2017

Natasa Tosic

23

1 reference

23 November 2017

Zdenek Racil

25

1 reference

23 November 2017

Michael Steurer

26

1 reference

23 November 2017

Sonja Pavlovic

27

1 reference

23 November 2017

Mario Cazzola

28

1 reference

23 November 2017

publication date

7 August 2012

1 reference

American Journal of Hematology

23 November 2017

published in

1 reference

23 November 2017

volume

87

1 reference

23 November 2017

issue

11

1 reference

23 November 2017

page(s)

1010-1016

1 reference

The myeloproliferative disorders

23 November 2017

cites work

1 reference

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

21 January 2018

1 reference

A gain-of-function mutation of JAK2 in myeloproliferative disorders

21 January 2018

1 reference

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

21 January 2018

1 reference

Acquired uniparental disomy of chromosome 9p is a frequent stem cell defect in polycythemia vera

21 January 2018

1 reference

Unraveling the molecular pathophysiology of myelodysplastic syndromes

21 January 2018

1 reference

Frequent pathway mutations of splicing machinery in myelodysplasia

21 January 2018

1 reference

Acquired mutations in TET2 are common in myelodysplastic syndromes

21 January 2018

1 reference

Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes

21 January 2018

1 reference

AML transformation in 56 patients with Ph- MPD in two well defined populations.

21 January 2018

1 reference

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

21 January 2018

1 reference

Clonal architecture of secondary acute myeloid leukemia

21 January 2018

1 reference

Acquisition of FLT3 or N-ras mutations is frequently associated with progression of myelodysplastic syndrome to acute myeloid leukemia

21 January 2018

1 reference

Characterization of NPM1-mutated AML with a history of myelodysplastic syndromes or myeloproliferative neoplasms.

21 January 2018

1 reference

Recurrent DNMT3A mutations in patients with myelodysplastic syndromes

21 January 2018

1 reference

IDH mutations in primary myelofibrosis predict leukemic transformation and shortened survival: clinical evidence for leukemogenic collaboration with JAK2V617F

21 January 2018

1 reference

Mutation in TET2 in myeloid cancers

21 January 2018

1 reference

Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1

21 January 2018

1 reference

Deletions of the transcription factor Ikaros in myeloproliferative neoplasms.

21 January 2018

1 reference

Frequent deletions of JARID2 in leukemic transformation of chronic myeloid malignancies.

21 January 2018

1 reference

Two routes to leukemic transformation after a JAK2 mutation-positive myeloproliferative neoplasm.

21 January 2018

1 reference

A patient with a 20-year lag phase between JAK2-V617F+ myeloproliferation and NPM1-mutated AML arguing against a common origin of disease.

21 January 2018

1 reference

Taxing sugar-sweetened beverages

21 January 2018

1 reference

Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patients

21 January 2018

1 reference

Runs of homozygosity in European populations

21 January 2018

1 reference

Detection of FLT3 Internal Tandem Duplication and D835 Mutations by a Multiplex Polymerase Chain Reaction and Capillary Electrophoresis Assay

21 January 2018

1 reference

Circos: an information aesthetic for comparative genomics

21 January 2018

1 reference

Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation

21 January 2018

1 reference

Cytogenetic findings in adult secondary acute myeloid leukemia (AML): frequency of favorable and adverse chromosomal aberrations do not differ from adult de novo AML.

21 January 2018

1 reference

CUX1 transcription factor is required for optimal ATM/ATR-mediated responses to DNA damage

21 January 2018

1 reference

The prognostic impact of 17p (p53) deletion in 2272 adults with acute myeloid leukemia

21 January 2018

1 reference

Clinical effect of point mutations in myelodysplastic syndromes

21 January 2018

1 reference

21 January 2018

1 reference

Treatment of polycythemia vera with hydroxyurea and pipobroman: final results of a randomized trial initiated in 1980.

21 January 2018

1 reference

Patients with de novo acute myeloid leukaemia and complex karyotype aberrations show a poor prognosis despite intensive treatment: a study of 90 patients

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/AJH.23309

1 reference

23 November 2017

1 reference